Horizon Kinetics Asset Management’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $109K | Sell |
51,484
-2,258
| -4% | -$4.76K | ﹤0.01% | 330 |
|
|
2025
Q1 | $65.6K | Hold |
53,742
| – | – | ﹤0.01% | 328 |
|
|
2024
Q4 | $69.3K | Buy |
53,742
+2,258
| +4% | +$2.91K | ﹤0.01% | 331 |
|
|
2024
Q3 | $142K | Sell |
51,484
-2,258
| -4% | -$6.21K | ﹤0.01% | 317 |
|
|
2024
Q2 | $121K | Hold |
53,742
| – | – | ﹤0.01% | 301 |
|
|
2024
Q1 | $128K | Hold |
53,742
| – | – | ﹤0.01% | 293 |
|
|
2023
Q4 | $89.2K | Sell |
53,742
-2,258
| -4% | -$3.75K | ﹤0.01% | 307 |
|
|
2023
Q3 | $108K | Hold |
56,000
| – | – | ﹤0.01% | 304 |
|
|
2023
Q2 | $80.6K | Hold |
56,000
| – | – | ﹤0.01% | 316 |
|
|
2023
Q1 | $118K | Buy |
56,000
+30,000
| +115% | +$63K | ﹤0.01% | 307 |
|
|
2022
Q4 | $29.4K | Hold |
26,000
| – | – | ﹤0.01% | 308 |
|
|
2022
Q3 | $42K | Hold |
26,000
| – | – | ﹤0.01% | 321 |
|
|
2022
Q2 | $34K | Hold |
26,000
| – | – | ﹤0.01% | 325 |
|
|
2022
Q1 | $42K | Buy |
26,000
+2,000
| +8% | +$3.23K | ﹤0.01% | 337 |
|
|
2021
Q4 | $50K | Hold |
24,000
| – | – | ﹤0.01% | 342 |
|
|
2021
Q3 | $93K | Hold |
24,000
| – | – | ﹤0.01% | 329 |
|
|
2021
Q2 | $77K | Buy |
+24,000
| New | +$77K | ﹤0.01% | 338 |
|